Guankui Wang
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 18
- Surfaces, Coatings and Films top 5%
- Immunology top 10%
- Complement system in diseases 13
- Pharmaceutical Science top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 4
-
- RNA Interference and Gene Delivery 9
-
- Gold and Silver Nanoparticles Synthesis and Applications 5
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Erythrocyte Function and Pathophysiology 3
- Co-authors
- Dmitri SimbergS. Moein MoghimiNirmal K. BandaV. Michael HolersLinping WuJames I. GriffinRodney A. HillRobert I. Scheinman
- Journals
- ACS Nano (8 papers)Nanomedicine Nanotechnology Biology and Medicine (4 papers)Journal of Controlled Release (4 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Guankui Wang
36 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Biomaterials 812
- Surfaces, Coatings and Films 144
- Immunology 373
- Pharmaceutical Science 91
- Biomedical Engineering 546
Countries citing papers authored by Guankui Wang
This map shows the geographic impact of Guankui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guankui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guankui Wang more than expected).
Fields of papers citing papers by Guankui Wang
This network shows the impact of papers produced by Guankui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guankui Wang. The network helps show where Guankui Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guankui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 26 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 18 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 243 | |
| 12 | 2017 | 29 | |
| 13 | 2017 | 14 | |
| 14 | 2017 | 45 | |
| 15 | 2016 | 61 | |
| 16 | Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivobreakdown → | 2016 | 455 |
| 17 | 2015 | 82 | |
| 18 | 2014 | 78 | |
| 19 | 2012 | 53 | |
| 20 | 2012 | 91 |
About Guankui Wang
Guankui Wang is a scholar working on Biomaterials, Immunology, Hematology, Genetics and Electronic, Optical and Magnetic Materials, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (18 papers), Complement system in diseases (13 papers), RNA Interference and Gene Delivery (9 papers), Gold and Silver Nanoparticles Synthesis and Applications (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Erythrocyte Function and Pathophysiology (3 papers). The work is most often cited by research in Biomaterials (812 citations), Surfaces, Coatings and Films (144 citations), Immunology (373 citations), Pharmaceutical Science (91 citations) and Biomedical Engineering (546 citations). Guankui Wang has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Dmitri Simberg, S. Moein Moghimi, Nirmal K. Banda, V. Michael Holers, Linping Wu, James I. Griffin, Rodney A. Hill, Robert I. Scheinman, Donald S. Backos and Fangfang Chen. Their work appears in journals such as ACS Nano, Nanomedicine Nanotechnology Biology and Medicine, Journal of Controlled Release, Frontiers in Immunology and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.